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CARDIOVASCULAR DISEASE COULD BE CONTAINED BASED ON
CURRENTLY AVAILABLE DATA!
Okom Nkili F.C. Ofodile  Center for Cardiovascular Research (CCR), Institute
of Pharmacology and Toxicology, AG: Theuring, Charite-Universitätsmedizin
Berlin, Hessische Str. 3-4, 10115 Berlin, Germany
 Largely due to better control of infectious diseases and significant advances in bio-
medical research, life expectancy worldwide has increased dramatically in the last three
decades. However, as the average age of the population has risen, the incidence of chron-
ic age-related diseases such as arthritis, Alzheimer’s, Parkinson’s, cardiovascular disease,
cancer, osteoporosis, benign prostatic hyperplasia, and late-onset diabetes have increased
and have become serious public health problem, as well. The etiology of these disorders is
still incompletely understood, therefore, neither preventive strategies nor long-term effec-
tive treatment modalities are available for these disorders. In keeping with the aforemen-
tioned, the ultimate goal in cardiovascular research is to prevent the onset of cardiovascu-
lar episodes and thereby allow successful ageing without morbidity and cognitive decline.
Herein, I argue that cardiovascular episodes could be contained with relatively simple
approaches. Cardiovascular disorder is characterized by cellular and molecular changes
that are commonplace in age-related diseases in other organ system, such alterations
include increased level of oxidative stress, perturbed energy metabolism, and “horror auto-
toxicus” largely brought about by the perturbation of ubiquitin -proteasome system, and
excessive oxidative stress damage to the cardiac muscle cells and tissues, and cross-reactions
of specific antibodies against human heat shock protein 60 with that of mycobacterial heat
shock protein 65.” Horror autotoxicus”, a Latin expression, is a term coined by Paul Ehrlich
at the turn of the last century to describe autoimmunity to self, or the attack of “self” by
immune system, which ultimately results to autoimmune condition. Based on the current-
ly available data, the risk of cardiovascular episodes and several other age-related disorders,
including cancer, Alzheimer’s disease and diabetes, is known to be influenced by the nature
and level of food intake. Now, a wealth of scientific data from studies of rodents and mon-
keys has documented the significant beneficial effects of calorie restriction (CR) or dietary
restriction (DR), and multiple antioxidant agents in extending life span and reducing the
incidence of progeroid-related diseases. Reduced levels of cellular oxidative stress, protec-
tion of genome from deleterious damage, detoxification of toxic molecules, and enhance-
ment of energy homeostasis, contribute to the beneficial effects of dietary restriction and
multiple antioxidant agents. Recent findings suggest that employment of DR and multiple
antioxidant agents (including, catalase, gluthatione peroxidase, CuZn superoxide dismu-
tase, and Mn superoxide dismutase = enzymes forming the primary defense against oxygen
toxicity), and ozone therapy may mount an effective resistance to pathogenic factors rele-
vant to the pathogenesis of cardiovascular episodes. Hence, while further studies will be
needed to establish the extent to which CR and multiple antioxidant agents will reduce
incidence of cardiovascular episodes in humans, it would seem prudent to recommend CR
and multiple antioxidant agents as widely applicable preventive approach for cardiovascu-
lar disorders and other progeroid-related disorders.
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INTRODUCTION
It is now well-established, based on a plethora of scientific data, that
strong link exists between the way a person or population lives and their
risk for developing or dying from cardiovascular diseases (CVD). Despite
the fact, that heredity has impacting role to play in events with regards
development of cardiovascular cases, for some people however, their per-
sonal health habits and environmental and/or cultural exposure are
highly important factors, that in most cases, surpass hereditary suscepti-
bility. For instance, adapting to a heart healthy diet, being physically
active and staying appropriately lean (Scranton et al., 2004), not smoking,
avoiding major stress (Black, 2002, 2003) and depression can directly lead
to accelerated prevention of cardiovascular episodes. Cardiovascular dis-
ease, including heart attack, stroke and heart failure, is believed to be the
leading cause of disease and death in the USA and Europe and is poised
to become the most significant health problem worldwide. Athero-
sclerosis, presently accepted as an inflammatory disease (Rose, 1999:
Libby, 2002) and an autoimmune reaction highly associated disease
(Wick and Xu, 1999; Pockley et al., 2000; Wick et al., 2001; Pankuweit et
al., 2002; Bason et al., 2003), constitutes the single most important con-
tributor to the growing burden of cardiovascular disease. 
PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASE
Atherosclerosis, an underlying cause of myocardial infarction, stroke
resulting in premature death, is a progressive disease consisting of focal
plaques characterized by cholesterol deposition, fibrosis, and inflamma-
tion in the large arteries. The first visible atherosclerotic lesion demon-
strates macrophage foam cells “fatty streak” and lipid droplets within inti-
mal smooth muscle cells (SMC) and heterogeneous droplets of extracel-
lular lipid followed by intimal thickenings (progressive-prone locations)
in young adults (Stary HC et al., 1994; Lusis,2000; Scott, 2004).
Complement activation
Activation and over-reactivity of the complement system belongs to
important factors intimately implicated in driving cardiovascular disease.
Complement, a double-edged sword, is a sophiscated essential compo-
nent of the innate immune system that largely contributes to the recog-
nition and destruction of pathogens and other invaders,and to assist in
the phogocytosis of waste materials. However, under certain conditions,
as it can be the case in most pathological conditions, inappropriate acti-
vation of the complement system could result to severe damage to the
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host. The major components of the complement system execute four
major functions: 1) recognition, 2) opsonization, 3) inflammatory stimu-
lation through anaphylatoxins, and 4) mediate killing through the mem-
brane attack complex (MAC). Membrane attack complex (MAC) is the
dimer of a fusion product of complement proteins C5b, C6, C7, C8, and
C9. MAC is directly responsible for complement-dependent membrane
damage and catalysis (see Methods for detailed discussion of complement
system; Quigg, 2002, Webster et al., 1997). 
There is now substantial evidence that circulating levels of the acute
phase reactant C-reactive protein (CRP) constitute a cardiovascular risk
factor. Concentration levels in healthy persons or patients with stable or
unstable angina pectoris are associated with stable or unstable angina pec-
toris are associated with an increased incidence of cardiovascular events
(Haverkate. et al. 1997; Ferreiros et al., 1999; Ridker et al., 1998).
Ventricular rupture occurs only in patients with peak serum CRP levels
higher than 200 mg/liter (Ueda et al., 1996), and high CRP levels predict
mortality over the next 6 months from all causes related to myocardial
infarction (Pietilä et al., 1996). Human CRP, after aggregation or ligand
binding, has been reprted to possess the potentials to activate complement
via the classical complement pathway, thereby implying that CRP may
strongly enhance inflammation by activating complement (Volanakis et
al., 1974; Wolbink et al., 1996; Wolbink et al., 1998; Torzewski et al., 1998).
Apoptosis
Apoptosis, a prominent event in the pathogenesis of cardiovascular
diseases, is a factor intimately associated with the orchestrated network of
inflammatory events in cardiovascular disease (Gustafsson and Gottlieb,
2003; Calkosinski et al., 2004; Scott, 2004) . Apoptosis is an active type of
cell death. It differs from necrosis in its programmed manner, complex
regulatory mechanisms, distintive morphological changes and lack of
inflammation (Wyllie AH et al., 1981, Graham and Chen, 2001). The inju-
rious stimuli as direct consequence of the actions of the aforementioned
patho-biological processes seems to be aggravation of endogenous oxida-
tive stress, leading to excessive oxidative modification of lipids, proteins,
and DNA, and thereby the structural and functional alterations within
the vascular wall (Cai H and Harrison, 2000; Ames BN, et al., 1993).
Oxidative Stress
Oxidative stress is caused by the presence of free radicals or radical-gen-
erating agents in concentrations that overwhelm natural radical-blocking
or -scavenging mechanisms. Sources of oxidative stress include exogenous
factors, such as cigarette smoke, and endogenous factors, such as oxidative
burst from activated macrophages. Oxidative stress can cause oxidative
damage to DNA, proteins, and lipids, and many clinical conditions includ-
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ing cardiovascular disease are associated with increased indices of oxidant
stress; thereby suggesting that overwhelming the antioxidant defense sys-
tem initiates and propagates processes involved in the pathogenesis of
many diseases (Halliwell and Gutteridge, 1990). Hence, in line with the
aforementioned, oxidative stress, although largely a secondary event, has
been shown by a huge body of data as the major driving force in the path-
ogenic cascade of events responsible for sustaining and exacerbation of the
disease process in atherosclerotic vascular disease, and therefore, strongly
suggests that the development and progression of atherosclerosis can be
inhibited by antioxidants (Berliner and Heinecke, 1996; Diaz et al., 1997),
and other measures such as calorie restriction (CR), and appropriate
employment of chemopreventive agents, such as cucurmin. 
Ubiquitin-Proteasome System (UPS)
Dysfunction of the ubiquitin-proteasome system (UPS) has been
implicated in driving cardiovasculatr disease by a huge body of scientific
data (Igarashi et al., 1994; Bulteau et al., 2001; Herrmann et al., 2003).
An important factor, which largely contributes to maintenance of the
homeostasis of the cells is the process of ubiquitin-proteasome catalytic
pathway. Normal cellular functioning requires processing of proteins reg-
ulating cells cycle, growth, and apoptosis. The UPS or the ubiquitin-pro-
teasome pathway (UBP) is the principal mechanism for proteolysis in the
mammalian cytosol and nucleus. The UPS modulates intracellular pro-
tein degradation. To this end, UPS fullfils important function in cell
defense : 1) removal of damaged proteins generated by adduct formation
and oxidatative stress, 2) regulates cell-cycle progression and apoptosis by
modulation of proteasomal p 53 degradation (Yang and Yu, 2003), 3) reg-
ulation of nucleocytoplasmic transport and gene transcription (Schwartz
and Hochstrasser, 2003). Hence, dysfunction or blokade of the proteaso-
mal degradation pathways results in accumulation of unwanted protein
and cell death. A total perturbation of the cellular homeostasis.
Importantly, recently accumulating data, consistent with the afore-
mentioned notion, strongly suggest that albeit that cardiovascular diseases
and neurodegenerative disorders such as Alzheimer’s disease (AD) display
different pathological outcome, they, however, sufficiently share common
pathogenic features, such as inflammation, over-reactivity of the comple-
ment system, ubiquitin-proteasome dysfunction and significant oxidative
stress-associated damage to the cells and viable tissues (Aliev et al., 2002;
Aliev et al., 2003; Aliev, 2002; Arlt et al., 2001; Miyakawa, 2002; Skoog and
Gustafson,2002; de La Tore, 2002; Rodin and Thomas, 2001; Zekry et al.,
2002; Berliner and Heinecke, 1996; Mayer et al.,1991;Layfield et al., 2001;
Yasojima et al., 2001; Lagrand et al., 1997; Li et al., 1995; Torzewski et al.,
1998; McGerr and McGerr, 2000; 2001: Igarashi et al., 1994; Bulteau et al.,
2001; Herrmann et al., 2003). Support for this notion explains the puzzle
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posed by seemingly unrelated drugs (drugs primarily produced for the
management of cardiovascular diseases that confer protection against neu-
rodegenerative pathological conditions (Jones et al., 1999; Tsuschida et
al., 1990; Feleszko et al., 1999; Stuve et al., 2003; Teunissen et al., 2003;
Zamrini et al., 2004). Furthermore, in agreement with this notion, a large
body of evidence implicates free radical toxicity, radical induced pertur-
bation of the ubiquitin-proteasome catalytic pathway (Mayer et al., 1991;
Layfieldet al., 2001;Herrmann J et al., 2003), radical induced mutations
and oxidative enzyme impairment and mitochondrial dysfunction, and
perturbation of the homeostasis of calcium in the brain (Marin-Garcia et
al., 2002; Sheehan et al., 1997; Calabrese et al., 2001; Golden and Melov,
2001; Nicholls, 2002; Aliev et al., 2003) in the clinical manifestation of neu-
rodegenerative and cardiovascular diseases. Unregulated accumulation of
oxidative damage in neurons and in the cardiac muscles either primarily
or secondarily may account for the increased incidence of a variety of neu-
rodegenerative diseases and cardiovascular pathological conditions.
Hence, consistent with the above observations, accumulating data favors
antioxidants agents and dietary calorie restriction (CR or DR) as potential
measures in the management of cardiovascular and neurodegenerative
diseases in humans. This strongly indicates that therapeutic strategies
worked out for effective management of cardiovascular disease may equal-
ly find efficacy in the management of some neurodegenerative disorders,
such as Alzheimer’s disease (AD). Hence, in agreement with the above
data, it is conceivable that appropriate employment of dietary calorie
restriction and multiple antioxidant agents may strongly impact an effec-
tive resistance to the pathogenic factors relevant to cardiovascular pathol-
ogy. While further investigations will be needed to establish to which
extent DR and antioxidant agents will attenuate the disease development
and progression in CVD, it would be prudent to recommend the employ-
ment of dietary calorie restriction and antioxidant agents as widely appli-
cable intervention, in form of potential adjuncts, for the management of
cardiovascular diseases. It is, thus, the subject of this article to discuss the
potential free radical scavenger, antioxidant actions, the promising bene-
ficial cardioprotective effects of DR and the need for the use of these
agents as potential adjuncts to the standard therapy in the management of
cardiovascular diseases, and alongside briefly treat the effect of the same
agents on neurodegenerative disease, such as Alzheimer’s disease. 
ANTIOXIDANT AGENTS 
It is now well established that during the course of normal metabolism,
reactive oxygen species (ROS) are produced from within the respiratory
chain of the mitochondria. These ROS have the ability to oxidize and dam-
age a variety of cellular constituents including lipids, carbohydrates, DNA,
and proteins. Oxygen, although essential for aerobic life, can be converted
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to highly reactive species, including superoxide ion, hydrogen peroxide,
and hydroxyl radical, as aforementioned, known collectively as reactive oxy-
gen species. Increased ROS formation, in particular, under pathological
conditions is believed to cause damage to the cells and tissues through
chemical interactions with proteins, lipids, carbohydrates and DNA. The
heart is supposed to be the most susceptible of all the organs to premature
aging and free radical-mediated oxidative stress. In agreement with this, a
large body of scientific evidence indicated that oxidative stress induced by
reactive oxygen species (ROS) play pivotal role in the etiology of several
chronic degenerative diseases, including cardiovascular disease (Berliner
and Heinecke, 1996; Sevanian and Hochstein, 1985; Aliev et al., 2002,
Nunomura et al., 2001; Sayre et al. 2001). Conversely, the brain and the
nervous system are considered to be highly susceptible to peroxide damage
than most organs and tissues due to their high content of iron, cate-
cholamine, excitatory amino acids, polyunsaturated lipid-rich neural
parenchyma, high oxygen utilization accounting for one fifth of the total
system consumption, low anti-oxidative enzymes, such as catalase (CAT),
superoxide dismutase (SOD), and glutathione peroxidase (GSHPX)
(Rouach et al., 1987; Patole and Ramasara, 1988; Haliwell B,1989; Juurlink
and Sweeney,1997). Oxidation of the circulating low-density lipoprotein
(LDL) that carry cholesterol into the blood stream to oxidized LDL
(LDLox) is believed to play a pivotal role in the pathogenesis of athero-
sclerosis, which, as previously described, is the underlying disorder
(Berliner and Heinecke, 1996). Therefore, the antioxidant potential
should be very important in the development and management of cardio-
vascular disorders. (Sies, 1993; Finkel and Holkrook, 2000; Halliwell, 1996;
Diaz et al., 1997; Diplock et al., 1998). Hence, a large number of anti-oxi-
dant agents have been shown to exhibit neuroprotective and cardioprotec-
tive effects in the cell culture and animal models relevant to age-associated
disorders. These include estrogen, caratenoids, uric acids, N-acetylcysteine,
Coenzyme Q10, lipoic acid, and Ginko biloba extract (Shepherd et al.,
2001; Karev et al., 1993; Pereira et al., 1999; McCarty, 2001; Prasad et al.,
1999; Mayne, 2003; Sole and Jeejeebhoy 2002; Jeejeebhoy et al., 2002; Hu,
2003; Diaz et al. 1997; Van der Loo et al., 2002). Nevertheless, extending on
each of every antioxidant agent will be beyond the scope of this articule,
however, it is wished in this articule to extend on vitamin E and Gluthatione
(GSH), and few other antioxidant agents that have major pivotal play in
cardioprotection and neuroprotection, as well.
Vitamin E
Epidemiological experimental studies have provided evidence for an
inverse relation between cardiovascular disease and antioxidant intake,
particularly, vitamin E supplementation (Gaziano and Hennekens, 1992;
Stampfer et al., 1993; Rimm et al., 1993).Vitamin E (alpha/gamma-toco-
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pherol) is a lipid soluble antioxidant that is very effective in suppressing
membrane lipid per-oxidation. Vitamin E cannot be produced in the
body of animals and humans. Foodstuffs, such as vegetables oils, nuts and
cod roe, are good sources of Vitamin E (Azzi and Stocker, 2000). The
term “Vitamin E” was introduced in the year 1922 (Evans and Bishop,
1922) when a new dietary factor in animal nutrition considered impor-
tant for reproduction was described. Isolation of two components with
vitamin E characteristics, designated as alpha- and beta-tocopherol, was
performed in the year 1936 from wheat oil. However, presently, a total of
about eight isomers are known to occur in nature. The nutritional impor-
tance of vitamin E was confirmed in the year 1968 by the American Food
Nutrition Board, and right from that time, a plethora of studies has con-
firmed its role in protecting the integrity of tissues by acting as chain
breaking antioxidant (Esterbauer et al., 1987; Butterfield et al.2002).
Vitamin E may counteract the effects of aging and neurodegenerative dis-
orders by suppressing membrane lipid per-oxidation and thereby pre-
serving membrane transporter function and stabilizing cellular ion
homeostasis (Goodman Y., Mattson MP, 1995; Mark et al., 1995;
Butterfield et al., 2002) and in cardiovascular disorder, by directly scav-
enging reactive oxygen species, as well (Carr et al., 2000). Vitamin E has
recently been shown to attenuate inflammatory damages in association
with vitamins A and C, after burn trauma, by markedly inhibiting the
translokation of the cardiac NF-kB (nuclear factor-kappa B), resulting in
decreased cardiac synthesis of inflammatory cytokines, and, thereby con-
ferring protection against burn-trauma mediated cardiac injury (Horton
et al., 2001). Consistent with the notion of involvement of common path-
ogenic features in AD pathology and in cardiovascular diseases, high dose
of vitamin E has earlier been reported to slow the progression of
Alzheimer’s disease (Sano et al., 1997). A randomized study by Chapell
and associates (Chapell et al., 1999) that combined supplementation of
vitamin E and C conferred protection against the frequency or reoccur-
rence of the pre-eclampsia syndrome. It should be very recommendable,
to employ vitamin E, in high levels, in combination with other antioxi-
dants, in order to counteract the occasional pro-oxidant reaction of vita-
min E, which can occur when vitamin E is administered alone. Consistent
with this notion, Bowry and Stocker (Bowry and Stocker, 1993; Bowry et
al., 1995) and Neuzil and associates (Neuzil et al., 1997) reported that
alpha-tocopherol can act as a pro-oxidant in LDL via alpha-tocopheroxyl
radical-mediated formation of lipid radicals. Hence, together, the above
observations strongly suggest that in absense, or rather in association,
with other efficient free radical scavengers, vitamin E will continue to be
one therapeutic strategy in CVD and neurodegenerative pathological
conditions characterized by oxidative stress and inflammatory processes
such as Alzheimer’s disease.
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Glutathione (GSH)
When cells are exposed to oxidative stress, GSH synthesis is increased
through up-regulation of glutamate-cysteine ligase (GCL) gene expres-
sion, providing a protective/adaptive mechanism against oxidative stress
(Meister A and Anderson ME, 1983; Moinova and Mulcahy, 1998;
Rahman and MacNee, 1999). Glutathione (GSH), ubiquitous tripeptide
thiols, is a major and naturally occurring antioxidant involved in many
cellular functions. GSH is, however, predominantly involved in the regu-
lation of intracellular redox state and protects cells from oxidative injury
(Meister A and Anderson ME, 1983). These includes protein and DNA
synthesis; enzyme activation; amino acid transport; and the protection
from the negative effects of radiation, oxygen radicals, and other reactive
oxygen intermediates (Bogden et al., 1994), such as glutathione peroxi-
dase catalyzed inactivation of hydrogen peroxide. Flohe et al. (Flohe et
al., 1999) recently revealed that survival and virulence of various parasites
depend on endogenous antioxidant defense systems, and GSH activity
was suggested to be implicated in this event. Furthermore, GSH in its
virtue as a major antioxidant in the brain has been shown to protect neu-
rons against a variety of oxidative insults in experimental models relevant
to the pathogenesis of AD, PD, ALS, and stoke (Keller et al., 1998; Mark
et al., 1997; Pederson et al., 1999). Now, as demonstrated in vitro studies,
GSH depletion inhibits nitric oxide (NO) production in endothelial cells.
In agreement with this, a plethora of data concludes that supplementa-
tion of GSH or its precursor improved endothelial vasomotor dysfunction
in patients with coronary risk factors in which oxidative stress has a path-
ogenic role (Kugiyama et al., 1998; Vita et al., 1998). Additionally, in com-
mensurate to this, “GSH stability” in the red blood cells (RBCs) both in
gestational hypertension and, in pre-eclampsia syndrome, a pathological
condition characterized by an increased blood pressure, proteinuria, and
edema (Roberts JM et al., 1989: Roberts JM and Redman C, 1993; ACOG,
1996) and excessive inflammatory responses and endothelial dysfunction
(Redman CW et al., 1999), is thought to be highly perturbed (Knapen M
et al., 1998). Consistent with this notion, the rate of GSH oxidation has
been shown by Spickert and colleagues (Spickert et al., 1998) to strongly
correlate to the severity of the illness and the susceptibility, as well.
Hence, the above data suggest a pivotal role for GSH as an antioxidant,
and further support the notion that appropriate administration of GSH
may significantly contribute to the prevention and management of car-
diovascular events.
Curcumin: a potent cytoprotector
Based on the notion of oxygen-stress theory of aging and age-associ-
ated chronic degenerative diseases (Harman, 1956), diet supplementa-
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tion with a number of phenolic or thiolic antioxidants have been able to
increase the life span of laboratory animals, protect against senescent
immune decline, repair damaged DNA molecules, and preserve the func-
tion of aged mitochondria (Miquel and Weber, 1990; Henning and Chow,
1988; Miquel et al., 1995; De la Fuente et al., 1998). Curcumin and other
antioxidant products from the dried rhizome of Curcuma longa are
believed to be useful for the prevention and/or treatment of a variety of
age-related degenerative processes (Ammon and Wahl, 1991). In keeping
with this notion, many lines of scientific evidence (Srimal and Dhawan.,
1973; Huang et al., 1988; Reddy and Lokesh, 1994; Mukhopadhyay et al.
1982; Ruby et al., 1995; Ramirez-Tortosa et al., 1999; Araujo and Leon,
2001; Balasubramayam et al., 2003; Calabrese et al., 2003) suggest that
that the main anti-oxidant from Curcuma (i.e. Curcumin) or 1.7-bis-(-4-
hydroxy-3-methoxiphenyl)-1,6-heptadiene-2,5-dione) as well as hydro-
alcoholic extract of dry Curcuma rhizome posses potential anti-inflam-
matory, immunomodulating, tumoricidal, antiprotozoal, antioxidant and
antiatherogenic properties. In vivo model studies carried out by Ramirez-
Tortosa and associate (Ramirez-Tortosa et al., 1999) demonstrated signif-
icant reduction of oxidation of serum LDL-cholesterol in a model of ath-
erosclerotic rabbits after intake of 1.6 mg/kg curcumin extract in the
diet. Additionally, in commensurate to this, administration of hydro-
alchoholic extract of curcuma to rabbits strongly decreased the plasma
level of cholesterol and the susceptibility of LDL to oxidation (Ramirez-
Tortosa et al., 1999). A plethora of clinical studies with humans further
substantiated the protective effects of curcumin and related products of
the dry rhizome of the spice plant C. longa against lipid peroxidation-
associated damages and other related cases (Ramirez-Bosca et al., 1995;
1997; Cheng et al., 2001). Now, most importantly, it is believed that phar-
macologically, there is no side effects by appropriate administration of
curcumin (Aggarwal et al., 2003), thereby, strongly indicative that using
of curcumin is not connected with any toxicity or negative side effects
(Cheng et al., 2001). Furthermore, most recent evidence, suggests that
high intake of curcumin of up to 800mg-2500mg daily was devoid of every
negative side effects (Chainami-Wu, 2003). Curcumin and related prod-
ucts have been shown to mediate their protective effects (antioxidant,
free radical scavenging, and anti-inflammatory, and anti-parasitic activity)
through a variety of pathways or mechanisms: 1) inhibition of Ca2+ influx
and protein kinase C (PKC) activity (Balasubramayam et al., 2003), 2)
Curcumin has also been shown to beneficial effects due to its ability to
strongly activate the haem oxygenase pathway (Scapagnini et al., 2002).
Haem oxygenase-1 (HO-1), a ubiquitous and redox-sensitive inducible
stress protein that degrades haem to CO, iron and biliverdin, is a ~32-kDa
microsomal enzyme that catalyzes the rate-limiting step in haem degra-
dation. Induction of HO-1 occurs as an adaptive and protective response
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to a variety of inflammatory stimuli (Maines, 1997). It has been revealed
that under severe hypoxic condition s the potency of curcumin to
increase endothelial Heam oxygenase-1 (HO-1) expression and, thereby,
consequently protect cells against oxidative stress is highly enhanced
(Motterlini et al., 2000), 3) by induction of the heat shock response
(Dunsmore et al., 2001), 4) suppression of the superoxide anion produc-
tion directly or indirectly through inhibition of xanthine dehydroge-
nase/xanthine oxidase (XD/XO) conversion (Kunchandry and Rao,
1990; Asser I et al., 2002), 5) through buffering of impaired
oxidant/antioxidant unbalance, thereby attaining the levels of thiobarbi-
turic acid-reactive substances (TBARS) similar to baseline levels and to
less reduced coenzyme Q10 levels thiobarbituric acid-reactive substances
(Quiles et al., 2002), 6) Curcumin ability to confer anti-inflammatory
effect (Chuang et al., 2000) and this effect is apparently due to the fact
that can influence the metabolisms of arachidonic acid blocking the
phosphorylation of cytosolic phospholipase A2 (cPLA2), decreasing the
expression of cyclooxygenase 2 (COX-2), and inhibiting the catalytic
activity of the inflammatory factor 5-lipoxygenase (5-LOX) (Skrzypezac-
Jankun et al., 2000; Hong et al., 2004), 7) recent study revealed that cur-
cumin can confer protection against lead-and cadmium induced oxida-
tive stress-damage to neuronal cells in an in vivo by effectively binding to
the metals to build a compound, thus, by chaleting mechanism (Daniel
et al., 2004). This indicates that curcumin also represents a potent phar-
macological target by metal poisoning, for it has got the property of
chaleting toxic metals, and finally, curcumin has been shown to enhance
the activities of detoxifying enzymes such as glutathione-S-transferase via
dose-dependent induction of increased activity of g-glutamyl cystein syn-
thetase (g-GCS), which catalyzes the rate-limiting step in GSH biosynthe-
sis (Piper et al., 1998). This action, which involves the detoxification of
the electrophilic toxic products lipid peroxidation is suggested to equal-
ly contribute to the anti-inflammatory and antioxidant properties of cur-
cumin. The molecular underpinnings responsible for the beneficial
effects observed by Curcumin has been suggested to be largely due to
modulation of pools of transcription factors that compose EpRE and AP-
1 complexes, which results in influencing gene expression of the gluta-
mate-cystein ligase (GCL) and other phase II enzymes (Dickinson DA et
al., 2003). Additionally, in commensurate to this, the antioxidant activity
of curcumin and its derivatives could be attributed to the 1,3-diketone
conjugated diene system, essential for scavenging of the oxygen radicals
than the phenolic and methoxy groups (Sreejayan and Rao,1994;
Kuchandy and Rao, 1990) and the ability of tetrahydrocurcumin via beta-
diketone moity to exhibit antioxidant activity by cleavage of the C-C bond
at the active methylene carbon between the two carbonyls (Pan et al.,
1999). Conversely, the anti-inflammatory activitiy of curcumin and its
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derivatives has been suggested to be due to the presence of hydroxyl and
phenol groups in the molecule, which are essential for the inhibition of
prostaglandins (PG synthetase) and leucotrienes (LT), and also due to
the presence of the beta-dicarbonylic system, equipped with the double
bonds(dienes).The presence of the a-dicarbonylic system, with its conju-
gated double bonds (dienes) is also believed to be responsible for
antiparasitic activity of curcumin and its derivatives (Araujo and Leon,
2001). Substantially, the above observations strongly indicate that cur-
cumin and its derivatives may be especially beneficial as potential anti-
atherogenic agents in the processes associated with a marked increase in
blood lipid peroxidation such as diabetes (Suresh Babu and Srinivasan,
1997), myocardial infarction and dislipemias in women, which mostly
accompany biochemical alterations after menopause (Miquel et al.,
1998). Therefore, curcumin and related products of the dry rhizome of
the spice plant C. longa could be employed both as preventive by patients
with peripheral vascular disease and equally in the management of the
concerned diseases, as well.
Ozone therapy and Cardioprotection
Controlled administration of ozone is thought to influence oxidative
stress, preventing the damage induced by reactive oxygen species and,
thereby, protecting against cases associated with ischaemia reperfusion
injury. Thus, appropriate administration of ozone in form of endovenous
ozone monotherapy to patents with myocardial infarction, where, as well-
established, decrease in glutathione peroxidation and superoxide dismu-
tase activities is commonplace (Loeper J et al., 1991), has been reported
to be beneficial. Ozone hemotherapy has been reported to induce the
stimulation of glutathione peroxidase activity (Hernandez F., et al. 1995)
and also to reduce the blood cholesterol level (Rilling, 1985), thereby
linking ozone therapy to peroxide and cholesterol metabolism. Support
for this notion is evidenced by studies carried out by Frank Hernandez
and associates (Hernandez et al., 1995). These investigators demonstrat-
ed the antioxidant beneficial effect of ozone autohemotherapy in human
subjects. After 15th session of ozone treatment, cholesterol (CHO) level
was shown to be significantly diminished and glutathione peroxidase
(GPx) activity significantly elevated. Despite the fact that the molecular
underpinnings responsible for the biochemical alterations associated
with ozone therapy have yet to be fully determined, ozone scavenger
enzyme stimulation is largely believed to have a role in this process.
Additionally, in commensurate to this, ozone treatment has been recent-
ly shown to considerably reduce markers of oxidative stress-associated
endothelial damage in vivo model of rats associated with diabetes (AL-
Dalain et al., 2001). Ozone therapy, when appropriately employed, is an
efficient approach in a position to confer adequate protection against
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lipid peroxidation which is thought as an important risk factor for ather-
osclerotic-related cardiovascular disease (Lusis, 2000). LDL is modified
by free radical-mediated reactions, both in their lipid and protein moi-
eties, resulting to the alterations that are the starting point for the first
event in the outcome and development of atherogenetic process (Lusis,
2000). Ozone therapy is relatively inexpensive and simpler than a variety
of surgical interventions. Therefore, in spite of the possible toxic effects
associated with ozone therapy, which is presently being proactively
addressed (Tylicki L et al., 2003), decreasing scavenger enzyme activity in
individuals with cardiovascular cases can be addressed or restored by
appropriate application of ozone autohemotherapy.In agreement with
the fact that cardiovascular disease share major pathogenic factors with
neurodegenerative disorders such as Alzheimer’s disease (Aliev et al.,
2002; Aliev et al., 2003; Aliev, 2002; Arlt et al., 2001; Miyakawa, 2002;
Skoog and Gustafson, 2002; de La Tore, 2002, 2004; Berliner and
Heinecke, 1996; Mattson and Kroemer, 2003; Sparks, 1997; Newman et
al., 2001; Hofman et al., 1997; Bulteau et al., 2001), it is thus conceivable
that appropriate application of ozone therapy be ameliorative, under cer-
tain conditions, in individuals with Alzheimer’s disease, as well.
Lycopene: evolving importance in chronic degenerative diseases
Data on the antioxidant potentials of Lycopene, a naturally present
carotenoid, and the exploitation of this potential in the management of
neurodegenerative diseases, cardiovascular disorders, and other chronic
degenerative conditions are increasingly accumulating. Agarwal and asso-
ciate recently reviewed the possible importance of lycopene in prevention
and management of various diseases (Agarwal et al, 2000). Lycopene, an
acylic isomer of beta-carotine with no provitamin A activity (Stahl et al.,
1996), is a carotinoid present in tomatoes, tomato products, watermel-
ons, pink grapefruits, apricots and pink guavas. Dimascio and associates
described lycopene as highly potent antioxidants, which possesses a sin-
glet oxygen quenching ability twice that of beta-carotene and ten times
than that of alpha-tocopherol (Dimascio et al., 1989). Earlier studies by
Agarwal and associate, reported that leocopene from tomato products is
absorbed readily, increasing serum levels and lowering the oxidative dam-
age to lipids, lipoproteins, proteins and DNA (Agarwal et al. 1988).
Support for this notion is strongly evidenced by more recent study, which
showed 50% loss of serum lycopene with a 25% increase in the in vivo
lipid oxidation following the ingestion of lycopene free diet for two weeks
in healthy human subjects (Rao et al., 1998). This is strongly indicative of
the potent antioxidant ability of lycopene. In keeping with this, lycopene
has been shown to significantly exert beneficial effects in subjects associ-
ated with diverse neurodegenerative conditions such as PD, AD and vas-
cular dementia (Foy et al., 1999). Longnecker and associates reported as
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a result of a case-control study that dietary administration of lycopene was
protective against cases of ALS (Longnecker et al., 2000). Earlier,
Snowdon and associates reported a corresponding correlation between
high blood lycopene level and a positive influence on the functional
capacity of the elderly, such as the capacity to perform self-care tasks
(Snowdon et al., 1996). Consistent with this notion, studies by Sinclair
and colleagues (1998) and by Clinton (1998) revealed that antioxidants
such as lycopene may act directly on neurons and by an in- direct manner
affecting peripheral markers of oxidative stress, and also strongly sug-
gested that lycopene may be capable of crossing the blood-brain barrier
(Sinclair et al., 1998; Clinton, S.K. 1998). Mechanisms underlying the
beneficial effects of lycopene have been recently briefly reviewed by
Heber and associate (Heber and Lu, 2002). Now, consistent with the fact
that Alzheimer’s disease share important key pathogenic factors with car-
diovascular disease (Aliev et al., 2002; Aliev et al., 2003; Aliev, 2002; Arlt
et al., 2001; Miyakawa, 2002; Skoog and Gustafson, 2002; de La Tore,
2002, 2004; Berliner and Heinecke, 1996; Mattson and Kroemer, 2003;,
Sparks, 1997; Newman et al., 2001; Hofman et al., 1997; Bulteau et al.,
2001; Herrmann et al., 2003), we are led to believe that appropriate
employment of lycopene as an antioxidant adjunct may equally be bene-
ficial in the management cardiovascular diseases. Support for this notion
is evidenced by relentlessly accumulating data attributing significant car-
dioproctive properties to lycopene (Rissanen et al., 2002; Sesso et al.,
2003; 2004). Furthermore, Arab and associate (Arab and Steck, 2000)
reported that the thickness of the innermost wall of blood vessels and the
risk of myocardial infarction are reduced in persons with higher adipose
tissue concentrations of lycopene. Thus, further studies on lycopene and
its properties may even lead to development of novel therapeutic strate-
gies through which cardiovascular conditions could be more effectively
contained. 
Salen Manganese Complexes
As briefly discussed above, antioxidant therapies have been employed
for a wide range of disorders in which oxidative stress is considered to
play a significant role. However, administration of single antioxidants
such as Vitamin E (Lipman et al., 1998) and endogenous SOD in various
clinical indications have produced extremely little or limited success. In
the attempt to improve this condition, Cerchiari and associates (Cerchiari
et al., 1987) demonstrated that the employment of combined superoxide
dismutase succeeded to regain cerebral blood flow and function after car-
diac arrest in mammal. This apparently encouraged the development of
very strong antioxidant agents in this direction, and eventually led the
investigators working at Eukarion, Inc, Susan R. Doctrow and associates
(Doctrow et al., 1997; Baker et al., 1998; Doctrow et al., 2002; Liu et al.,
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2003) to develop synthetic antioxidant mimetics, equipped with both
SOD and catalase activities (properties). These products have been
shown to be potentially efficative against reactive oxygen species-associat-
ed pathological conditions, and aging-associated alterations (Doctrow et
al., 1997; Baker et al., 1998; Doctrow et al., 2002; Liu et al., 2003; Melov
et al., 2000). Salen Manganese complexes are low molecular weight syn-
thetic compounds that have both superoxide dismutase and catalase
activities, thereby mimicking two endogenous enzymes involved in the
first-line of antioxidant defence against ROS. The prototypes of these syn-
thetic Salen Manganese Complexes are: EUK-8, EUK-108, EUK-122, EUK-
121, EUK-15, EUK-123, EUK-113, EUK- 13, EUK-124, EUK-115, EUK- 114,
EUK-160, and EUK-189 Doctrow, SR. (Doctrow et al., 2002). This article
will, however, concentrate on the antioxidant effects of the two proto-
types, EUK-8 and EUK-134. Salen-Manganese complexes have the ability
to catalytically scavenge multiple ROS, including superoxide ion and
hydrogen peroxide. This depicts salen manganese complexes as poten-
tially valuable agents for combating a wide range of conditions in which
oxidative stress is implicated. 
Cytoprotective effects of Salen-Manganese Complexes
Salen-Manganese Complexes have been shown to be highly effica-
cious as potential cytoprotective agents in experiments where they were
tested for protection in human dermal fibroblasts (HF cells) against glu-
cose and glucose oxidase, a hydrogen peroxide-generating system. EUK-
8, EUK-134 and EUK-189 have been demonstrated to be highly effective
in protecting primary neurons and PC12 cells from toxicity by the per-
oxide-generating agent sin-1, Anderson and associates (Anderson et al,
2002). They have also been shown to be very effective in inhibiting apop-
tosis in primary neurons and highly efficacious as antioxidant agents in a
mouse model for mitochondrial oxidative stress (Melov et al., 2001). 
Salen-Manganese Complexes may be Beneficial in Extension of 
Lifespan in Mammals
Studies on nematode Caenorhabditis elegance (C. elegans), which is
widely used as a model for research in aging, by Melov and associates
(Melov et al. 2000) demonstrated the an increase in mean lifespan aver-
aging about 40% of life span by administration of either EUK-8 nor EUK-
134. The EUK compounds extended lifespan without affects on growth or
reproduction. This finding was further extended and buttressed by the
studies of Ishii et al. (Ischii, et al., 1998). These investigators, utilizing the
mev-1 (Kn1) nematode in their experiments reported that treatment of
EUK-134 resulted in extension of Lifespan by over 60%, thereby lending
support to the hypothesis that therapeutic employment of EUK-134 caus-
es a decrease in chronic oxidative stress in mev-1 mutant, effectively, nor-
malizing its lifespan to approximate that of the wild type. Thus, the above
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described points imply: 1) that age-associated loss of neurological func-
tions in mammals can (could) be partially reversed through the supple-
mentation of antioxidants, 2) apparently age-related decline in cognitive
function in humans could be reduced by consuming diets rich in antiox-
idants or through supplementing diet with appropriate antioxidants, 3)
since cardiovascular disease share major pathogenic factors with some
aging-associated neurodegenerative disorders such as Alzheimer’s disease
(Aliev et al., 2002; Aliev et al., 2003; Aliev, 2002; Arlt et al., 2001;
Miyakawa, 2002; Skoog and Gustafson,2002; de La Tore, 2002, 2004;
Berliner and Heinecke, 1996; Mattson and Kroemer, 2003; Sparks, 1997;
Newman et al., 2001; Hofman et al., 1997; Bulteau et al., 2001), appro-
priate employment of salen-manganese complexes in the management of
cardiovascular disease may be of enormous benefit.
Essentially, the data above collectively suggested that: 1) These two
catalytic antioxidants, Euk-8 and Euk-134, strongly mimic the catalytic
activities of both superoxide dismutase and catalase, and are convincing-
ly more effective than non-catalytic antioxidants such as vitamin C or E,
2) Salen-manganese complexes (SOD-mimetics with catalase activity, such
as EUK-8 and EUK-134) may represent novel therapeutic approach, in
their properties as potential antioxidant agents, for preventing and treat-
ing oxidative-stress related conditions, and 3) that multiple functional
catalytic antioxidant may serve as a very effective therapeutic approach,
which will be applicable to a broad range of chronic degenerative patho-
logical conditions and possibly to the enhancement of health during the
aging process. Hence, a combination of appropriate multiple micronu-
trients (including antioxidants) with dietary calorie restricting measures
may be more effective, than a single agent, in the management, and as an
adjunct to standard therapy in the management of cardiovascular disease
than the individual agent.
DIETARY RESTRICTION (DR) 
There is now credible and overwhelming evidence that dietary restric-
tion (DR) is the only effective experimental manipulation known to
extend lifespan and retard aging in mammals, and it has been shown to
retard a variety of processes that change with age. (Weindruch and
Walfort, 1988; Yu et al., 1985; Blackwell et al., 1995). Despite the fact that
most studies conducted on dietary restriction have been in rodents and
lower animals, a large body of accumulating data from studies on rhesus
monkeys strongly suggests that the beneficial effects of DR may also be
extrapolated to primates, including humans (Zainal et al., 2000; Roth et
al., 2001; Ingram et al., 2004; Lane et al., 2004; Hursting SD et al., 2003;
Knight, 1999). Dietary Restriction, which means reduced calorie intake,
maintained at 60 % of ad libitum intake, thus represents a well-established
means of prolonging the life span in mammals and increase their resist-
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ance to cancer, cardiovascular diseases, diabetes, and other age-related dis-
eases (Knight,1999; Yu, 1994; Sohal and Weindruch 1996; Yu et al., 2002).
On the other hand, the term, calorie restriction literally and commonly
refers to a reduction in calorie intake without a reduction in essential
nutrients or malnutrition (Yu, 1994). Thus, dietary restriction, indeed, dif-
fers from severe fasting or starvation in that it reduces total caloric or ener-
gy intake without causing deficiencies of any specific nutrients. It was
reported for the first time in 1930s that food restriction significantly
extends the life span of rodents (McCay et al. 1935). It, thus, also exerts
beneficial effects on the brain including enhanced learning and memory
and increased neuronal resistance to excitotoxic, oxidative and metabolic
insults. There are numerous nutritional factors and other measures that
have been reported to affect the brain and heart physiologically in a way
that could, at least, in theory beneficially influence brain and cardiovas-
cular ageing in non-pathological and as well as in pathological states.
However, it is wished to focus here mainly on the factor of dietary restric-
tion (DR; reduced calorie intake: maintained on 60% of ad libitum feed-
ing). Dietary restriction is also known as calorie restriction (CR). 
Despite the fact that CR benefits have been known for many years, the
mechanism(s) of its action are still incompletely resolved. Its complexity
seemingly lies in multiple cascade of events that involves a broad spec-
trum of physiological, biochemical, endocrinological, and metabolic
effects, which may vary in intensity and exhibit striking differences
among specific organ systems A variety of mechanisms have been sug-
gested to underlie the beneficial effect of calorie restriction, including
reduction in oxidative stress (Sohal and Weinruch, 1996; Kristal and
Yu,1994), “membrane peroxidation cycle 2 concept” a novel phenome-
non by which dietary restriction (maintained on 60% of ad libitum feed-
ing) suppresses age-related oxidative damage by modulation the amount
of fatty acid composition and also that of fatty acid composition of tissue
phospholipids (Yu et al., 2002), by increasing the expression of apoptosis
repressor with a caspase recruitment domain (ARC) (Shelke and
Leeuwenburgh, 2003), by upregulation of heat shock protein 70, glucose-
regulator protein and brain-derived neurotrophic factor (BDNF) (Duan
and Mattson,1999; Yu and Mattson, 1999; Guo et al., 2000), by enhancing
the fidelity of DNA replication, thereby promoting DNA stability
(Srivastava et al, 1998; Horton et al. 2000; Cabelof et al. 2003), positively
modulating (suppressing the increase of COX-2 in the brain) the activity
cyclooxygenase 2 (COX-2) (Baek et al., 2001), by increased expression of
immunosuppressive TFG-beta 1, positively modulating the balance
between Th-2 and Th-1 cytokine, and blocking the expression of inter-
leukin 10 (IL-10) and some other immunoactive pro-inflammatory
cytokines, thereby conferring enormous protection against excessive
immune reactions such as autoimmune reaction (Abe et al., 2001;
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Chandrasekar et al., 1995; Jolly et al., 1999; Sun et al., 2004), and respon-
sible for detoxification of a variety of toxic substances in the body (Hart
et al., 1992, 1995). In keeping with the aforementioned, recent studies
have shown that DR can stabilize mitochondrial function and reduce
oxidative stress in brain cells of rodents (Guo et al, 2000), and thus may
increase the resistance of neurons to many different types of genetic and
enviromental features. CR also upregulates several antioxidants including
catalase, glutathione reductase, glutathione S-transferase, and superoxide
dismutase (Koizumi et al., 1987; Langaniere, and Yu, 1989). A wealth of
scientific data demonstrates, in a number of genotypes and species that
CR can also inhibit chronic toxicity induced by physical, chemical, and
microbial agents (Turturro and Hart, 1992; Hart and Turturro, 1993;
Chou et al., 1993).
CR has also been reported to reduce age-associated neuronal loss in
most mouse models of neurodegenerative disorders such as Parkinson’s
disease (Duan and Mattson 1999) or Alzheimer’s disease (Zhu et al.
1999). CR also improves the brain’s plasticity and ability for self-repair
(Mattson, 2000). Now, conversely, CR has been shown by a wealth of sci-
entific data to confer beneficial effects on a variety of cardiovascular
pathological conditions. Blood pressure is decreased by CR in the obese
and in chronically undernourished laborers (Apfelbaum, 1978; Shetty
and Kurpad, 1990). Landsberg and associate (Landsberg and Young,
1981; 1983) demonstrated that calorie CR is implicated in a decrease in
plasma norepinephrine concentration, decreased excretion of cato-
cholamines, and, perhaps in diminished sympathetic activity. This, there-
fore, indicates that the decrease in blood pressure during CR may be
mediated by decrease in insulin concentration and sympathetic nervous
activity (Velthuis-te Wierik et al., 1994). CR has also been reported to pos-
itively impact on endothelial dysfunction such as endothelial-dependent
vasodilatation in obese hypertensive subjects (Sasaki et al., 2002). CR also
reduces markers for inflammation including C-reactive protein, inter-
leukin 6, and plasminogen activator inhibitor type 1 in obese and
nonobese subjects (Heilbronn et al., 2001; Bastard et al., 2000; Marvri et
al., 2001; Velthuis-te Wierik et al., 1995). This notion is further evidenced
by Chandrasekar and associates (Chandrasekar et al., 2001) reporting
that CR significantly reduced myocardial oxidative stress and the postis-
chemic inflammatory response to myocardial ischemia-reperfusion
injury in Male Fisher rats. This observation has been further strength-
ened by the works of other research groups (Roberts et al., 2002; Abete
et al., 2002). Additionally, Taffet and colleagues earlier disclosed that CR
is intimately associated with the prevention of age-related impairments in
the late diastolic function (Taffet et al., 1997). Moreover, recent report by
Mattson and co-workers (Wan et al., 2004) robustly indicated that CR
should be beneficial for the management of both cardiovascular and neu-
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rodegenerative diseases. Taken together, the aforementioned observa-
tions strongly buttress the concept that moderately restricting dietary
calories is potentially cytoprotective, and, thus, should have pivotal role in
both prevention and management of cardiovascular disease.
Molecular underpinnings responsible for the beneficial effects of 
calorie restriction 
A variety of pathways and phenomena have been suggested to under-
lie the molecular underpinnings responsible for the biochemical alter-
ations registered in the actions of calorie restricting measures, neverthe-
less, the phenomenological process of hormesis appears to be pivotal in
this event (Masoro EJ, 1999; Masoro EJ, 2000a, 2000b; Rattan SL, 2004).
Hormesis: evolving importance in dietary caloric restriction
The term hormesis by definition describes the beneficial, biological
effect at low levels, as seen in reduced calorie intake, which at higher lev-
els would cause deleterious effects (Calabrese and Baldwin, 1998, 2002).
As previously described, a plethora of studies on CR have established its
efficacy as the most robust and effective life-prolonging intervention,
extending both average and maximum life span. Studies of Parson P.A.
(Parson, 1996) and that of Holliday R. (Holliday, 1989), coupled with a
plethora of more recent other studies on extended longevity, have led us
to also believe that CR’s resistive action against stress is an evolutionary,
adapted measure, which is largely characteristic of a hormetic response.
Thus, the phenomenological process or the concept of hormesis may
offer a biological basis for such a phenomenon by CR (Neafsey, 1990).
This strongly indicates, as suggested by Weindruch R. and co-workers
(Lee et al., 1999; Weindruch et al., 2002) that an organism’s adaptive
response to CR was acquired through evolution by its turning on proper
genes essential for a high metabolically efficient state for the survival of
the species. Thus, elucidating the cellular and molecular underpinnings
responsible for the phenomenological process of hormesis may bear rel-
evance to effective management of ageing-associated alterations, and age-
ing-associated pathological alterations, and other chronic degenerative
conditions in humans and animals.
Thus, essentially, all the experimental evidence suggests that dietary
restriction may be an important approach for mitigating of processes that
leads to diseases where oxidative stress and inflammation play pivotal role
such as neurodegenerative diseases, cancer, rheumatoid arthritis and car-
diovascular diseases, as well. Therefore, since this measure takes advan-
tage of components involved in simple nutrition, the application of
caloric restriction measures to improve public health may be highly wel-
comed and easy to establish. Hence, whatever the reason for the evolu-
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tion of CR, however, because of its potent anti-oxidant and neuroprotec-
tive and cardioprotective actions and its apparent extrapolation to
humans, elucidation of its mechanism(s) may add more tools to the stan-
dard therapy used to combat cardiovascular disease, neurodegenerative
disorders, and other chronic diseases. It is, thus, conceivable, based on
the above data, that appropriate employment of DR should be equally
beneficial in the prevention and management of cardiovascular disease
CONCLUSIONS
Cardiovascular disease, including heart attack, stroke and heart fail-
ure, is believed to be the leading cause of disease and death in the USA
and Europe and is poised to become the most significant health problem
worldwide. As a result the societal cost attributed to cardiovascular disor-
der is immense and is poised to get worse. This clearly underscores the
urgent need for the medical community to seek new therapies that can
reduce the frequency of cardiovascular disorder and impact. Despite the
fact that cardiovascular disorder is multifactorial in its etiology, neverthe-
less, there remain some potential for disease prevention and more effec-
tive management by employment of various antioxidant agents, and
dietary caloric restriction measures, because these measures may play
important role in modulating blood lipids and their propensity for oxi-
dation. Cardiovascular disease share various important pathogenic fac-
tors with some chronic diseases, which are characterized by dysfunction
of ubiquitin-proteasome system, oxidative stress and accelerated inflam-
matory processes, ranging from neurodegenerative disorder such as
Alzheimer’s disease (Aliev et al., 2002; Aliev et al., 2003; Aliev, 2002; Arlt
et al., 2001; Miyakawa, 2002; Skoog and Gustafson,2002; de La Tore, 2002;
Rodin and Thomas, 2001; Zekry et al., 2002; Berliner and Heinecke,
1996; Mayer et al.,1991;Layfield et al., 2001; Torzewski et al., 1998;
Igarashi et al., 1994; Bulteau et al., 2001; Herrmann et al., 2003) to dia-
betes mellitus and rheumatoid arthritis (Sevanian and Hochstein, 1985;
Halliwell et al., 1986; Onorato et al., 1998; Brod, 2000). This broadly
implies, that, appropriate employment of agents to effectively manage
rheumatoid arthritis, for instance, may confer some protection against
cardiovascular disease and also neurodegenerative pathological condi-
tions, such as Alzheimer’s disease and multiple sclerosis, as well (McGeer
et al., 1996; Ossandon et al., 2002; Greig et al., 2004; Ofodile:
Rheumatoid Arthritis, a Double-faced Syndrome: relevance to neurode-
generative disorder. In prep). Conversely, this type of link appears to be
very strong between cardiovascular disease and Alzheimer’s disease, as
previously described (Jones et al., 1999; Tsuschida et al., 1990; Feleszko et
al., 1999; Stuve et al., 2003; Teunissen et al., 2003; Zamrini et al., 2004).
Therefore, this work further strengthens the concept that therapeutic
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strategies worked out for the management of cardiovascular disease may
equally find significant efficacy in the management of some other chron-
ic pathological states characterized by oxidative stress and inflammatory
processes, in particular, Alzheimer’s disease. Hence, appropriate and con-
sequent incorporation of dietary calorie restriction (CA) measures and
antioxidant agents, as potential adjuncts, into the armamentarium of the
standard therapy for cardiovascular disease, should be, therefore, an
ideal approach for prevention strategies and more effective disease man-
agement that are simple and comparatively inexpensive.
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